COMP <GO>
TFX vs ABBV // OPERATING MARGIN
Teleflex Incorporated (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: TFX 3
— ABBV 12
▲ OPERATING MARGIN LEADER: ABBV
LAST: $139.77 (-1.15%) • MKT CAP: $5.99B
operating-margins
5.90%
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
operating-margins
24.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TFX VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TFX | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.20% | 70.20% | -14.00 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.80% | 29.00% | -27.20 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 40.9x | 33.3x | +7.60 | ABBV | /valuation <GO> |
| Free Cash Flow Yield | -18.00% | 3.47% | -21.47 | ABBV | /fcf-yield <GO> |
| Operating Margin ACTIVE | 5.90% | 24.60% | -18.70 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -45.40% | 6.90% | -52.30 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 17.20% | 8.60% | +8.60 | TFX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.01% | 2.27% | -1.26 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.12 | 5.33 | -3.21 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 7.40% | -0.60 | TFX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.9 | 72.8 | -4.86 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 1.15 | -0.17 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.0x | 113.1x | -86.10 | TFX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.99B | $513.86B | -$507.87B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TFX REV | ABBV REV | TFX GROSS % | ABBV GROSS % | TFX FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.99B | $61.16B | 56.2% | 70.2% | -$1.11B | $17.82B |
| FY 2024 | $1.70B | $56.33B | 61.0% | 70.0% | -$11.9M | $17.83B |
| FY 2023 | $1.71B | $54.32B | 44.0% | 44.0% | $323.4M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TFX // BETA 0.98
ABBV // BETA 1.15